Annal D Meleth

  • Citations Per Year
Learn More
Fundus autofluorescence (FAF) represents a relatively new imaging modality that has been investigated in a variety of uveitic disease processes. Autofluorescence was first described in the setting of fluorescein angiography (FA) as ‘‘pseudofluorescence’’ before injection of fluorescein dye. FAF relies on the presence of innate fluorophores within ocular(More)
PURPOSE To evaluate the safety and possible efficacy of subconjunctival sirolimus for the treatment of chronic active anterior uveitis. DESIGN Prospective, nonrandomized, open-label clinical trial. METHODS This single-center pilot trial enrolled 5 patients with chronic active anterior uveitis. The study drug was administered as a single subconjunctival(More)
Diabetes remains the leading cause of visual impairment among working-age adults in the United States. As the prevalence of diabetes grows, so too does the burden of visual loss on patients. The natural history of proliferative diabetic retinopathy (PDR) is poor, with approximately 44% of patients experiencing severe visual loss (<5/200) within 5 years of(More)
PURPOSE To examine the incidence and prevalence of osteonecrosis in uveitis patients. METHODS An electronic medical record database search was conducted to identify uveitis patients with osteonecrosis and the number at risk for corticosteroid-related osteonecrosis from 2003 to 2012. The clinical and ophthalmologic features of the uveitis patients with(More)
PURPOSE To characterize the retinopathy of prematurity (ROP) and survival of infants born at gestational age (GA) of 22-25 weeks. METHODS This study was a comparative case series for the total set of 78 infants ≤25 GA screened for ROP at a level IV NICU during a 21-month period. Data are presented on infants screened for ROP from 6 weeks after birth for(More)
  • 1